Ascenta Therapeutics
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
€182—273m (Dealroom.co estimates Apr 2007.)
Malvern Iowa (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$6.0m | Series A | ||
$30.0m | Series B | ||
$50.0m | Series C | ||
| N/A | $1.8m | Debt | |
| Total Funding | €78.2m | ||